Return to Results

Phase 1 Study of the Biologic Lung Volume Reduction (BLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema

new search

Trial Conditions
  • Pulmonary Emphysema
What is the purpose of this trial?

The purpose of this study is to evaluate the safety of the Biologic Lung Volume Reduction System (BLVR) for patients with advanced emphysema.

Date & Status


Who can Participate?


40 and older



Inclusion Criteria:

- Clinical diagnosis of advanced heterogeneous emphysema

- Age >/= 40

- Clinically significant dyspnea

- Failure of standard medical therapy to relieve symptoms

- Pulmonary function tests with protocol-specified ranges

Exclusion Criteria:

- Alpha-1 protease inhibitor deficiency

- Tobacco use within 16 weeks of initial clinic visit

- Body mass index < 15 kg/m2 or > 35 kg/m@

- Clinically significant asthma, chronic bronchitis or bronchiectasis

- Allergy or sensitivity to tetracycline

- Prior lung volume reduction surgery, prior lobectomy or pneumonectomy, prior lung
transplantation, prior endobronchial valve placement, prior airway stent placement or
prior pleurodesis

Gender: Both
  • St. Elizabeth's Medical Center - Completed
Trial Interventions
  • BLVR System
Other Information

Sponsor: Aeris Therapeutics
Phase: Phase 1
Trial ID: NCT00347659
Volunteers:  Not Accepting Healthy Volunteers

new search

Connect with Steward

Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

Subscribe to our patient e-newsletter

Copyright © 2015 Steward Health Care
Connect Healthcare Panacea CMS Solutions